Wysong A, Somani A, Ibrahim S, Cañueto J, Fitzgerald A, Siegel J, Prasai A, Goldberg M, Farberg A, Kasprzak J, Brodland D, Koyfman S, Arron S. Incorporating the 40-Gene Expression Profile (40-GEP) Test within Each Clinicopathologic Staging System Improves Metastatic Risk-Stratification in Patients Diagnosed with Cutaneous Squamous Cell Carcinoma (cSCC) and One or More High Risk Factors. J of Skin [Internet]. 2024Jan.16 [cited 2024Sep.20];8(1):s334. Available from: https://dermsquared.com/skin/article/view/2455